We provide evidence that MBA proteins exhibit high affinity and specificity to human and mouse recombinant or cell surface-exposed PD-1 receptors and can be used as non-immunoglobulin alternatives for monitoring PD-1+ cell populations in tumor tissue biopsy samples as well as for imaging of organs/tissues containing PD-1+ cells in vivo. Here, PDCD1 is linked to neoplasm.